4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099125
Chief Medical Officer sold 2,321 shares at an average $45.12 ($104,727)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-08-19 | Sale 10b5-1 | −2,060 | $45.01 | $92,721 | 143,483 | D |
| Farwell Wildon Chief Medical Officer | 2024-08-19 | Sale 10b5-1 | −261 | $46.00 | $12,006 | 143,222 | D |
| Open-market sales · 2,321 sh · avg $45.12 · $104,727 | |||||||
Loading xslF345X05/ownership.xml…